Miruvor
Sign up
Long COVID Outcome unclear

Long COVID: fatigue and returning dysautonomia after starting peptides

Condition
Long COVID
At worst
Not stated
Ill for
Not stated
Last post
Sep 2025
In their words
  • Condition: Long COVIDI just started BC 157, Thymosin Alpha 1 and KPV In context ↗
Read from 1 of their posts and comments; links to the one this page draws on

Request to remove this story

Summary

This person started BC 157, Thymosin Alpha 1 and KPV in September 2025. They reported an initial reaction of fatigue and a return of some dysautonomia symptoms, which they understood to be a normal early response. Nothing further about how the peptides went or how they are now is described.

Ask Miruvor AI

Asking aboutTide 69340’s story

What they tried

Their words about each treatment
  • BC 157 · WorseI just started BC 157, Thymosin Alpha 1 and KPV. It sounds like it's normal to have a reaction in the beginning (for me it's fatigue and return of some dysautonomia symptoms) In context ↗

Adverse events

  • BPC-157“for me it's fatigue and return of some dysautonomia symptoms” In context ↗ Side effects
  • BPC-157“for me it's fatigue and return of some dysautonomia symptoms” In context ↗ Made symptoms worse

Symptoms mentioned

Their words about their symptoms
  • POTS & dysautonomiareturn of some dysautonomia symptoms In context ↗

Ask Miruvor AI

Asking aboutTide 69340’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime